athagoras has acquired confinis ag, enhancing its regulatory and compliance capabilities in the Life Sciences sector across Europe and North America.
Information on the Target
Founded in 2005 and headquartered in Düdingen, Switzerland, confinis ag is a consulting firm that specializes in regulatory affairs, quality assurance, and compliance solutions tailored for the MedTech and pharmaceutical sectors across Europe and North America. The company has established a strong reputation characterized by its scientific depth and operational excellence, fostering long-term, trust-based relationships with over 100 active clients.
confinis offers a comprehensive range of services, including regulatory submissions, quality management system (QMS) implementation, clinical documentation, and post-market support. With its innovative approach and dedication to excellence, confinis is poised to become a strategic addition to the athagoras platform.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The regulatory consulting industry in Switzerland is marked by a robust demand for services that ensure compliance with stringent international standards in the life sciences sector. Switzerland is home to numerous pharmaceutical and medic
Similar Deals
NeuroX Group SA → Relief Therapeutics Holding SA
2025
Relief Therapeutics Holding SA → NeuroX Group SA
2025
Vista Klinik Holding AG → AVANTI, Centro Ticinese di chirurgia ambulatoriale SA
athagoras
invested in
confinis ag
in 2025
in a Merger deal